Robert W. Watkins - Concepedia

Author

Robert W. Watkins

Bloomfield College

Also Known As

ROBERT W. WATKINS, Robert W Watkins, Robert W. Watkins, Robert Watkins, Robert William Watkins

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Bloomfield College Stanford University AGCO (United Kingdom)

About

Robert W. Watkins is an author at Bloomfield College specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	514
2	Engineering	4	4	131
3	Natural Sciences	2	2	26
4	Health Sciences	1	1	11
5	Anesthesia	1	1	19

Robert W. Watkins

Publications

984

Citations

H-Index

Page 1

	Year	Citations
Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1(<i>R</i>)-4-(trifluoromethyl)phenyl}ethyl-3(<i>S</i>)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist Jayaram R. Tagat, Stuart W. McCombie, Dennis V. Nazareno, Journal of Medicinal Chemistry Excellent Receptor SelectivityImmunologyHiv-1 InhibitorsPharmacotherapyAntiviral Drug	2004	136
A total internal‐reflection technique for the examination of protein adsorption Robert W. Watkins, Channing R. Robertson Journal of Biomedical Materials Research	1977	114
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs Harry R. Davis, Kathyrn K. Pula, Kevin B. Alton, Metabolism Oxysterol3-Hydroxy-3-methylglutaryl CoenzymeBiochemistryReductase InhibitorsMedicine	2001	93
Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity Ho-Sam Ahn, Ana Bercovici, George Boykow, Journal of Medicinal Chemistry	1997	80
SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals Galen Carey, William Billard, Herbert Binch, European Journal of Pharmacology Molecular PharmacologyLaboratory AnimalsMedicineNeurotransmitterNeuropharmacology	2001	76
The Effect of Microscopic Core Heterogeneity on Miscible Flood Residual Oil Saturation A. P. Spence, Robert W. Watkins SPE Annual Technical Conference and Exhibition Rock TestingEngineeringWell StimulationMicroscopic HeterogeneityAxial Dispersion	1980	69
Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor Subbarao Vemulapalli, Robert W. Watkins, Madhu Chintala, Journal of Cardiovascular Pharmacology	1996	62
Synthesis and Evaluation of Polycyclic Pyrazolo[3,4-<i>d</i>]pyrimidines as PDE1 and PDE5 cGMP Phosphodiesterase Inhibitors Yan Xia, Samuel Chackalamannil, Michael Czarniecki, Journal of Medicinal Chemistry	1997	53
Topical Ocular Hypotensive Effects of the Novel Angiotensin Converting Enzyme Inhibitor SCH 33861 in Conscious Rabbits Robert W. Watkins, Thomas Baum, Karen Cedeno, Journal of Ocular Pharmacology and Therapeutics HypertensionOcular DiseaseCardiovascular PharmacologyPharmacotherapyOcular Pharmacology	1987	45
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism Ho Sam Ahn, David Eardley, Robert W. Watkins, Biochemical Pharmacology Cardiac MuscleCardiomyopathyCardiovascular DiseaseMedicinePhysiology	1986	39

Page 1